特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
707335

世界の血管造影装置市場:市場規模、市場シェア、市場分析 - 製品、技術、用途、エンドユーザー、地域別 - 成長率、動向、予測

Angiography Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 115 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
世界の血管造影装置市場:市場規模、市場シェア、市場分析 - 製品、技術、用途、エンドユーザー、地域別 - 成長率、動向、予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 115 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の血管造影装置市場は、2018年から2023年にかけて4.5%のCAGRで推移することが予測されています。心血管疾患の有病率の上昇、先進血管造影装置の承認、政府および官民連携による投資の増加、啓発活動の増加、血管造影装置の導入数の増加などが当市場の主な成長要因となっています。

当レポートでは、世界の血管造影装置市場を調査し、市場の概要、製品・技術・用途・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 血管造影装置市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 市場動向

  • 市場の成長要因
    • 非冠動脈造影実施件数の増加
    • 心臓血管疾患の発生率の上昇
    • 啓発活動による血管造影市場の推進
    • 重要な製品の発売
  • 市場の阻害要因
    • 血管造影に関連するリスク
    • 重大な製品リコール
  • 市場機会
  • 主な課題

第7章 世界の血管造影装置市場:セグメント別

  • 製品別
    • 血管造影システム
    • 消耗品
  • 技術別
    • MRI
    • CT
    • X線
    • その他
  • 用途別
    • 大脳
    • 頚動脈
    • 抹消血管
    • 大動脈
    • 冠動脈
    • その他
  • エンドユーザー別
    • 病院
    • 診断センター
    • 外来外科センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第8章 企業プロファイルと競合状況

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • GE Healthcare
  • Abbott
  • Medtronic PLC
  • Philips N.V
  • 島津製作所
  • Siemens Healthcare

第9章 市場の将来展望

目次
Product Code: 62804

The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.

Key Market Trends

The Hospital Segment is Expected to Dominate the Market During the Forecast Period

The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital's treatment capability.

North America Dominates the Angiography Devices Market

North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.

Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.

Competitive Landscape

The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Growing Demand for Interventional Angiography in Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 High Procedure and Equipment Cost
    • 4.3.2 Risks Associated with Angiography Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Angiographic Systems
    • 5.1.2 Consumables
      • 5.1.2.1 Catheters
      • 5.1.2.2 Guidewires
      • 5.1.2.3 Contrast Media
      • 5.1.2.4 Incision Closure Devices
      • 5.1.2.5 Accessories
  • 5.2 By Technology
    • 5.2.1 MRI
    • 5.2.2 CT
    • 5.2.3 X-ray
    • 5.2.4 Other Technologies
  • 5.3 By Application
    • 5.3.1 Cerebral
    • 5.3.2 Carotid
    • 5.3.3 Peripheral
    • 5.3.4 Aortic
    • 5.3.5 Coronary
    • 5.3.6 Other Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Centers
    • 5.4.3 Ambulatory Surgical Centers
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AngioDynamics Inc.
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Abbott Laboratories
    • 6.1.4 Cardinal Health Inc.
    • 6.1.5 GE Healthcare
    • 6.1.6 Medtronic PLC
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Shimadzu Corporation
    • 6.1.9 Siemens Healthineers AG
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.